Interleukin-2
Details
Drug Relations
- Drug Relations
DrugBank ID Name Drug group Pharmacological action? Actions Details DB02555 SP4160 experimental unknown Details DB02581 N(2)-carbamimidoyl-N-{2-[4-(3-{4-[(5-carboxyfuran-2-yl)methoxy]-2,3-dichlorophenyl}-1-methyl-1H-pyrazol-5-yl)piperidin-1-yl]-2-oxoethyl}-D-leucinamide experimental unknown Details DB03453 Methyl (2S)-2-[[2-[(3R)-1-carbamimidoylpiperidin-3-yl]acetyl]amino]-3-[4-(2-phenylethynyl)phenyl]propanoate experimental unknown Details DB03957 SP2456 experimental unknown Details DB04278 2-[2-(2-Cyclohexyl-2-guanidino-acetylamino)-acetylamino]-N-(3-mercapto-propyl)-propionamide experimental unknown Details DB05299 Keyhole limpet hemocyanin approved, investigational unknown Details DB05304 Girentuximab investigational unknown Details DB03372 3-Mercapto-1-(1,3,4,9-Tetrahydro-B-Carbolin-2-Yl)-Propan-1-One experimental unknown Details DB03455 (1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid experimental unknown Details DB00852 Pseudoephedrine approved unknown inhibitor Details DB01327 Cefazolin approved unknown inhibitor Details DB06584 TG4010 investigational unknown Details